F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
34.93
0.00 (0.00%)
Apr 2, 2026, 4:00 PM EDT - Market closed
LFSC Holdings Information
LFSC is an equity ETF with a total of 43 individual holdings. The top holdings are Cogent Biosciences stock at 8.56%, LivaNova at 7.02%, Spyre Therapeutics at 5.22%, Mirum Pharmaceuticals at 5.17%, and United Therapeutics at 5.13%.
Total Holdings
43
Top 10 Percentage
53.64%
Asset Class
Equity
ETF Category
Health
Assets
93.18M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | COGT | Cogent Biosciences, Inc. | 8.56% |
| 2 | LIVN | LivaNova PLC | 7.02% |
| 3 | SYRE | Spyre Therapeutics, Inc. | 5.22% |
| 4 | MIRM | Mirum Pharmaceuticals, Inc. | 5.17% |
| 5 | UTHR | United Therapeutics Corporation | 5.13% |
| 6 | TVTX | Travere Therapeutics, Inc. | 5.09% |
| 7 | KALV | KalVista Pharmaceuticals, Inc. | 4.82% |
| 8 | GH | Guardant Health, Inc. | 4.37% |
| 9 | NKTR | Nektar Therapeutics | 4.14% |
| 10 | BBIO | BridgeBio Pharma, Inc. | 4.11% |
| 11 | SVRA | Savara Inc. | 3.90% |
| 12 | TMDX | TransMedics Group, Inc. | 3.79% |
| 13 | TRVI | Trevi Therapeutics, Inc. | 2.88% |
| 14 | ICUI | ICU Medical, Inc. | 2.62% |
| 15 | AXSM | Axsome Therapeutics, Inc. | 2.35% |
| 16 | CYTK | Cytokinetics, Incorporated | 2.12% |
| 17 | CORT | Corcept Therapeutics Incorporated | 1.86% |
| 18 | PVLA | Palvella Therapeutics, Inc. | 1.79% |
| 19 | CBLL | CeriBell, Inc. | 1.76% |
| 20 | MANE | Veradermics, Incorporated | 1.74% |
| 21 | COLL | Collegium Pharmaceutical, Inc. | 1.71% |
| 22 | CRVS | Corvus Pharmaceuticals, Inc. | 1.55% |
| 23 | ITGR | Integer Holdings Corporation | 1.54% |
| 24 | GMED | Globus Medical, Inc. | 1.53% |
| 25 | BLLN | BillionToOne, Inc. | 1.51% |
As of Apr 1, 2026